How should a 17-year-old female with primary amenorrhea be evaluated and managed?

Evaluation and Management of Primary Amenorrhea in a 17-Year-Old

A 17-year-old with primary amenorrhea requires immediate systematic evaluation starting with pregnancy testing, followed by assessment of pubertal development, hormonal profile (FSH, LH, estradiol, prolactin, TSH), and pelvic imaging to categorize the cause into one of four compartments: hypothalamic-pituitary dysfunction, ovarian failure, anatomic abnormalities, or other endocrine disorders 1, 2.

Initial Diagnostic Workup

The evaluation must be algorithmically structured based on the presence or absence of secondary sexual characteristics:

Laboratory Testing (All Patients)

• Pregnancy test first (always rule out pregnancy regardless of sexual history)
• Serum FSH, LH, estradiol levels
• Prolactin and TSH
• Karyotype if indicated by exam or hormone levels 3, 1

Physical Examination Focus

• Assess Tanner staging of breast and pubic hair development
• Height, weight, BMI trends over time
• Presence/absence of uterus and vagina (external exam initially)
• Signs of hyperandrogenism (hirsutism, acne)
• Neurologic symptoms or visual field defects 1, 2

Imaging

• Pelvic ultrasound (transvaginal when possible, transabdominal if not sexually active) to assess:
  • Uterine presence and size
  • Ovarian size and antral follicle count
  • Anatomic abnormalities 3

Diagnostic Algorithm Based on Results

If Secondary Sexual Characteristics Present (Breasts Developed)

High FSH (>20-30 IU/L) = Ovarian Failure:

• Obtain karyotype (Turner syndrome, 46XY gonadal dysgenesis)
• Anti-21-hydroxylase antibodies
• Consider premature ovarian insufficiency 3

Low/Normal FSH with Normal Anatomy:

• Check prolactin (hyperprolactinemia)
• Consider functional hypothalamic amenorrhea
• Screen for eating disorders, excessive exercise, stress 4
• Assess for polycystic ovary syndrome features

Normal Hormones with Anatomic Abnormality:

• Imperforate hymen (14.6% of cases) 5
• Transverse vaginal septum
• MRKH syndrome (most common anatomic cause at 41.5%) 5

If No Secondary Sexual Characteristics (No Breast Development)

High FSH = Primary Ovarian Failure:

• Karyotype mandatory (Turner syndrome most common)
• Initiate puberty induction immediately 3, 6

Low FSH = Hypothalamic-Pituitary Dysfunction:

• MRI of pituitary/hypothalamus
• Constitutional delay (12.2% of cases) 5
• Kallmann syndrome
• Functional hypothalamic amenorrhea from LEA 4

Management by Etiology

Premature Ovarian Insufficiency/Hypogonadism

Hormone replacement therapy is mandatory and must continue until age 51 years minimum 3. This is critical for:

• Bone density preservation (obtain baseline DEXA)
• Cardiovascular health
• Quality of life
• Uterine development for potential fertility

Puberty Induction Protocol (If No Pubertal Development)

• Start 17β-estradiol transdermal at low dose (25 µg patches, can be cut for very low initial dosing)
• Begin between ages 11-13; do not delay beyond age 12 3
• Gradually increase dose over 2-3 years
• Target physiological levels: ~100 µg transdermal or 2 mg oral daily
• Add progesterone only after ≥2 years of estrogen OR if spontaneous bleeding occurs 3, 6

Critical pitfall: Oral contraceptive pills are NOT appropriate for puberty induction—they provide supraphysiological hormone levels and may compromise growth and bone development 3.

Maintenance HRT (If Puberty Already Complete)

• 17β-estradiol: 100 µg transdermal patch or 2 mg oral daily
• Transdermal route preferred (avoids hepatic first-pass, no thromboembolism risk) 3
• Add cyclic progesterone (at least 3 weeks per month if uterus present)
• Can use continuous progesterone if patient wishes to avoid withdrawal bleeding 3

Reassurance point: HRT at physiological doses in young women with POI carries no increased breast cancer risk—it replaces deficient hormones, unlike postmenopausal HRT 3.

Anatomic Abnormalities

Obstructive lesions require immediate surgical intervention to prevent complications:

• Imperforate hymen: simple hymenectomy
• Transverse vaginal septum: surgical excision 7
• MRKH syndrome: neovagina creation timed near anticipated sexual activity 7

Common pitfall: Delaying surgery in obstructive cases leads to endometriosis, adhesions, and chronic pain. Operate promptly for cyclic pain 7.

Functional Hypothalamic Amenorrhea

This diagnosis requires exclusion of organic causes first. Management focuses on:

• Nutritional rehabilitation if eating disorder present
• Reduce excessive exercise intensity/volume
• Address psychological stressors
• Bone density monitoring (high fracture risk with prolonged hypoestrogenism)
• Consider HRT if bone density declining despite lifestyle modifications 1, 4

Critical consideration: P-FHA in adolescence represents chronic low energy availability during a critical developmental window—early intervention is essential to prevent irreversible bone loss and growth impairment 4.

If Contraception Needed

• Combined oral contraceptives are first-line when contraception required (provide both hormone replacement and contraception) 3
• Progestin-only methods are inadequate (no estrogen replacement)
• Remember: 4-6% of POI patients achieve spontaneous pregnancy—discuss contraception needs 3

Additional Considerations

Karyotype 46XY (Complete Androgen Insensitivity or Gonadal Dysgenesis):

• Gonadectomy required (malignancy risk)
• Then initiate estrogen replacement

Chromosomal disorders found in 24.4% of primary amenorrhea cases in tertiary settings 5, making karyotyping essential when FSH elevated or phenotypic abnormalities present.

Psychosocial support is mandatory—primary amenorrhea profoundly affects body image, gender identity, and fertility expectations. Multidisciplinary care including psychology improves long-term outcomes 2, 6.